Literature DB >> 29388821

Diagnosis of Chronic Obstructive Pulmonary Disease: Breathing New Life into an Old Debate.

Surya P Bhatt1,2,3.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29388821      PMCID: PMC5822406          DOI: 10.1513/AnnalsATS.201709-733ED

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


× No keyword cloud information.
  12 in total

1.  Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.

Authors:  Peter Lange; Bartolome Celli; Alvar Agustí; Gorm Boje Jensen; Miguel Divo; Rosa Faner; Stefano Guerra; Jacob Louis Marott; Fernando D Martinez; Pablo Martinez-Camblor; Paula Meek; Caroline A Owen; Hans Petersen; Victor Pinto-Plata; Peter Schnohr; Akshay Sood; Joan B Soriano; Yohannes Tesfaigzi; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2015-07-09       Impact factor: 91.245

2.  Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.

Authors:  Prescott G Woodruff; R Graham Barr; Eugene Bleecker; Stephanie A Christenson; David Couper; Jeffrey L Curtis; Natalia A Gouskova; Nadia N Hansel; Eric A Hoffman; Richard E Kanner; Eric Kleerup; Stephen C Lazarus; Fernando J Martinez; Robert Paine; Stephen Rennard; Donald P Tashkin; MeiLan K Han
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

Review 3.  An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Authors:  Bartolome R Celli; Marc Decramer; Jadwiga A Wedzicha; Kevin C Wilson; Alvar A Agustí; Gerard J Criner; William MacNee; Barry J Make; Stephen I Rennard; Robert A Stockley; Claus Vogelmeier; Antonio Anzueto; David H Au; Peter J Barnes; Pierre-Regis Burgel; Peter M Calverley; Ciro Casanova; Enrico M Clini; Christopher B Cooper; Harvey O Coxson; Daniel J Dusser; Leonardo M Fabbri; Bonnie Fahy; Gary T Ferguson; Andrew Fisher; Monica J Fletcher; Maurice Hayot; John R Hurst; Paul W Jones; Donald A Mahler; François Maltais; David M Mannino; Fernando J Martinez; Marc Miravitlles; Paula M Meek; Alberto Papi; Klaus F Rabe; Nicolas Roche; Frank C Sciurba; Sanjay Sethi; Nikos Siafakas; Don D Sin; Joan B Soriano; James K Stoller; Donald P Tashkin; Thierry Troosters; Geert M Verleden; Johny Verschakelen; Jorgen Vestbo; John W Walsh; George R Washko; Robert A Wise; Emiel F M Wouters; Richard L ZuWallack
Journal:  Eur Respir Rev       Date:  2015-06

Review 4.  Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.

Authors:  Firdaus A A Mohamed Hoesein; Pieter Zanen; Jan-Willem J Lammers
Journal:  Respir Med       Date:  2011-02-05       Impact factor: 3.415

5.  Clinical and Radiologic Disease in Smokers With Normal Spirometry.

Authors:  Elizabeth A Regan; David A Lynch; Douglas Curran-Everett; Jeffrey L Curtis; John H M Austin; Philippe A Grenier; Hans-Ulrich Kauczor; William C Bailey; Dawn L DeMeo; Richard H Casaburi; Paul Friedman; Edwin J R Van Beek; John E Hokanson; Russell P Bowler; Terri H Beaty; George R Washko; MeiLan K Han; Victor Kim; Song Soo Kim; Kunihiro Yagihashi; Lacey Washington; Charlene E McEvoy; Clint Tanner; David M Mannino; Barry J Make; Edwin K Silverman; James D Crapo
Journal:  JAMA Intern Med       Date:  2015-09       Impact factor: 21.873

6.  Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?

Authors:  David M Mannino; A Sonia Buist; William M Vollmer
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

7.  Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.

Authors:  Surya P Bhatt; Jessica C Sieren; Mark T Dransfield; George R Washko; John D Newell; Douglas S Stinson; Gideon K D Zamba; Eric A Hoffman
Journal:  Thorax       Date:  2013-03-23       Impact factor: 9.139

8.  Fixed ratio or lower limit of normal as cut-off value for FEV1/VC: an outcome study.

Authors:  Per Wollmer; Gunnar Engström
Journal:  Respir Med       Date:  2013-07-08       Impact factor: 3.415

9.  Computed tomography structural lung changes in discordant airflow limitation.

Authors:  Firdaus A A Mohamed Hoesein; Pim A de Jong; Jan-Willem J Lammers; Willem Pthm Mali; Michael Schmidt; Harry J de Koning; Carlijn van der Aalst; Matthijs Oudkerk; Rozemarijn Vliegenthart; Bram van Ginneken; Eva M van Rikxoort; Pieter Zanen
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

10.  Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.

Authors:  Timothy Tilert; Charles Dillon; Ryne Paulose-Ram; Eva Hnizdo; Brent Doney
Journal:  Respir Res       Date:  2013-10-09
View more
  3 in total

1.  Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.

Authors:  Surya P Bhatt; Pallavi P Balte; Joseph E Schwartz; Patricia A Cassano; David Couper; David R Jacobs; Ravi Kalhan; George T O'Connor; Sachin Yende; Jason L Sanders; Jason G Umans; Mark T Dransfield; Paulo H Chaves; Wendy B White; Elizabeth C Oelsner
Journal:  JAMA       Date:  2019-06-25       Impact factor: 56.272

2.  Update in Chronic Obstructive Pulmonary Disease 2018.

Authors:  Wassim W Labaki; Lucas M Kimmig; Gökhan M Mutlu; MeiLan K Han; Surya P Bhatt
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

3.  Validated methods to identify patients with asthma-COPD overlap in healthcare databases: a systematic review protocol.

Authors:  Joseph Emil Amegadzie; Oluwatosin Badejo; John-Michael Gamble; Mark Wright; Jamie Farrell; Brooke Jackson; Kirin Sultana; Maimoona Hashmi; Zhiwei Gao
Journal:  BMJ Open       Date:  2019-03-13       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.